From 4817.06$

alvimopan

Peripheral opioid receptor antagonists

Scoring is done by our AI based assistant on the data from the FDA and other sources

7.4

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

7.8

Methylnaltrexone bromide (Oral)

7.5

Methylnaltrexone (Subcutaneous)

7.4

Symproic

7.4

Naldemedine

7.4

Relistor

7.4

Alvimopan

7.0

Movantik

6.1

Methylnaltrexone (oral/injection)

6.0

Relistor (Oral)

5.3

Relistor (Subcutaneous)

5.2

Naloxegol

5.2

Entereg